GlaxoSmithKline to Cut 350 R&D Jobs

June 12, 2008
Cuts represent 2% of the R&D workforce

GlaxoSmithKline said June 12 it planned to cut 350 jobs in its research and development departments worldwide as part of a restructuring plan launched last October.

"We continue to reshape our R&D operations to take advantage of new scientific opportunities and improve GSK's productivity," a spokesman for the group said, saying the total cuts would be 2% of the R&D workforce or 350 jobs.

GlaxoSmithKline, the biggest British pharmaceutical company that employs 100,000 people, launched a cost-cutting plan last Ocotober aiming to save $1.4 billion annually from 2010.

Copyright Agence France-Presse, 2008

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!